The Fibrosis-4 (FIB-4) Index for Liver Fibrosis is a non-invasive scoring system based on several laboratory tests that help to estimate the amount of scarring in the liver.
Fibrosis-4指数有助于确定慢性HBV感染相关肝癌风险 我国台湾大学医院金山分院Tseng等近日完成的一项研究表明,对于无肝硬化的慢性HBV感染患者,其肝纤维化标志物肝纤维化(FIB)-4指数<1.29时,发生肝细胞癌(HCC)的风险最低。 该项研究共纳入2075例基线时无肝...
3,4 Chronic disease progression in patients with these liver diseases can lead to the development of fibrosis, cirrhosis, and associated complications such as hepatocellular carcinoma.2,3,5 Liver disease severity is characterized in part by the presence of advanced fibrosis, which is d...
(Fibrosis-4 index,F4I)与右心室功能及预后的相关性.方法 选取 2017 年 1 月 ~2018 年 12 月辽阳市中心医院收治的 116 例 HFpEF 患者为研究对象.采用全自动生化分析仪测定血清血肌酐(Serum creatinine,SCr),总胆红素(total bilirubin, TBil),血红蛋白(hemoglobin,Hb),天冬氨酸氨基转移酶(aspartate ...
The aim of this study is to test the predictive value of the validated Fibrosis-4 (FIB-4) Index and compared it to liver transaminases and to the AST-to-Platelet ratio index (APRI). Multicenter cohort study including 992 consecutive COVID-19 patients admitted to the Emergency Department. ...
fibrosis-4(FIB-4)index,COVID-19 severity,and outcomes were recorded and compared according to the degree of liver enzyme elevation and the presence of ... HI Shousha,S Afify,R Maher,... - 世界胃肠病学杂志:英文版 被引量: 0发表: 2021年 Abstract 10354: Long-term Prognostic Value of the...
Fibrosis-4 (FIB-4) to exclude advanced fibrosis.1 Patients with low FIB-4 values should be managed in primary care, those with intermediate test results receive further diagnostics by an enhanced liver fibrosis test or ultrasound based elastography methods while those with high FIB-4 score are ...
fibrosis and cirrhosis. Area Under Receiver operating characteristic (AUROC) curve was used to demonstrate the predictive performance of non-invasive continuous variables for advanced fibrosis and cirrhosis. We included validated thresholds for APRI > 2 for cirrhosis, and FIB-4 > 3.25 for ...
Aside from FibroScan, various alternative non-invasive methods have been developed for the assessment of liver fibrosis in NAFLD during the past decade, such as aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio, fibrosis-4 (FIB-4) score, and AST to platelet ratio index (APRI) [...
Likely advanced fibrosis was present in 4% at baseline and was associated with an increased risk of HFpEF [HR (95% confidence interval)] [1.70 (1.3–2.3)]; and non-significantly with HFrEF [1.20 (0.9–1.7)]. These associations were not modified by HIV or hepatitis C status. Conclusion ...